Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0168 USD | +17.96% | +9.09% | -73.75% |
Sales 2022 | 16.84 1.35K | Sales 2023 | 18.22 1.46K | Capitalization | 1.28M 103M |
---|---|---|---|---|---|
Net income 2022 | -76M -6.08B | Net income 2023 | 53M 4.24B | EV / Sales 2022 | 4,528,434 x |
Net Debt 2022 | 68.36M 5.47B | Net Debt 2023 | 43.37M 3.47B | EV / Sales 2023 | 2,451,077 x |
P/E ratio 2022 |
-0.05
x | P/E ratio 2023 |
1.2
x | Employees | 38 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Latest transcript on Evofem Biosciences, Inc.
1 day | +17.96% | ||
1 week | +9.09% | ||
Current month | -30.29% | ||
1 month | -35.38% | ||
3 months | -51.86% | ||
6 months | -78.97% | ||
Current year | -73.75% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 31/12/12 | |
Ivy Zhang
DFI | Director of Finance/CFO | 46 | 28/02/18 |
Amy Raskopf
IRC | Investor Relations Contact | - | 31/01/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 31/12/12 | |
Kim Kamdar
BRD | Director/Board Member | 56 | 31/12/17 |
Colin Rutherford
BRD | Director/Board Member | 65 | 31/12/17 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.0168 | +17.96% | 555,899 |
25/04/24 | 0.0142 | -4.70% | 178,028 |
24/04/24 | 0.0149 | +16.04% | 740,620 |
23/04/24 | 0.0128 | -19.25% | 1,921,977 |
22/04/24 | 0.0159 | +3.25% | 157,974 |
Delayed Quote OTC Markets, April 26, 2024 at 08:58 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-73.75% | 929K | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- EVFM Stock